loading
Relay Therapeutics Inc stock is traded at $6.215, with a volume of 842.40K. It is down -4.23% in the last 24 hours and up +56.02% over the past month. Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
See More
Previous Close:
$6.50
Open:
$6.6
24h Volume:
842.40K
Relative Volume:
0.45
Market Cap:
$1.07B
Revenue:
$25.55M
Net Income/Loss:
$-341.97M
P/E Ratio:
-2.2196
EPS:
-2.8
Net Cash Flow:
$-304.44M
1W Performance:
+11.36%
1M Performance:
+56.02%
6M Performance:
+157.23%
1Y Performance:
-8.46%
1-Day Range:
Value
$6.1601
$6.68
1-Week Range:
Value
$5.47
$7.00
52-Week Range:
Value
$1.775
$7.07

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Name
Relay Therapeutics Inc
Name
Phone
617-370-8837
Name
Address
60 HAMPSHIRE STREET, CAMBRIDGE
Name
Employee
197
Name
Twitter
Name
Next Earnings Date
2025-02-21
Name
Latest SEC Filings
Name
RLAY's Discussions on Twitter

Compare RLAY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RLAY
Relay Therapeutics Inc
6.22 1.12B 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.56 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.33 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.46 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
800.99 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
330.86 35.16B 4.56B -176.77M 225.30M -1.7177

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-04-25 Resumed Guggenheim Buy
Apr-17-25 Initiated Wells Fargo Equal Weight
Sep-10-24 Resumed Goldman Buy
Sep-10-24 Upgrade Jefferies Hold → Buy
Sep-10-24 Downgrade Oppenheimer Outperform → Perform
May-10-24 Upgrade Barclays Equal Weight → Overweight
Apr-20-23 Upgrade Jefferies Underperform → Hold
Apr-19-23 Upgrade Raymond James Outperform → Strong Buy
Apr-13-23 Initiated Raymond James Outperform
Feb-03-23 Initiated Oppenheimer Outperform
Sep-30-22 Initiated Barclays Equal Weight
Sep-02-22 Initiated Stifel Buy
Jun-06-22 Initiated Jefferies Underperform
Feb-01-22 Initiated Berenberg Buy
Jul-21-21 Initiated BofA Securities Buy
Dec-15-20 Reiterated H.C. Wainwright Buy
Dec-08-20 Initiated JMP Securities Mkt Outperform
Nov-05-20 Initiated H.C. Wainwright Buy
Aug-10-20 Initiated Cowen Outperform
Aug-10-20 Initiated Goldman Buy
Aug-10-20 Initiated Guggenheim Buy
Aug-10-20 Initiated JP Morgan Neutral
View All

Relay Therapeutics Inc Stock (RLAY) Latest News

pulisher
10:16 AM

Using Bollinger Bands to evaluate Relay Therapeutics Inc.2025 Risk Factors & Daily Chart Pattern Signals - newser.com

10:16 AM
pulisher
09:11 AM

Key metrics from Relay Therapeutics Inc.’s quarterly dataTrade Risk Assessment & Free Daily Entry Point Trade Alerts - newser.com

09:11 AM
pulisher
08:01 AM

What MACD and RSI say about Relay Therapeutics Inc.Weekly Stock Summary & Smart Money Movement Alerts - newser.com

08:01 AM
pulisher
05:40 AM

Will Relay Therapeutics Inc. stock benefit from green energy trendsWeekly Trend Report & Verified Technical Trade Signals - newser.com

05:40 AM
pulisher
02:40 AM

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

02:40 AM
pulisher
01:28 AM

Relay Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Review & Comprehensive Market Scan Reports - newser.com

01:28 AM
pulisher
Oct 12, 2025

Relay Therapeutics Inc. stock prediction for this weekEntry Point & Weekly High Potential Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Multi asset correlation models including Relay Therapeutics Inc.Market Sentiment Summary & Weekly Momentum Stock Picks - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Relay Therapeutics (NASDAQ:RLAY) Trading Up 7.5%Should You Buy? - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Can trapped investors hope for a rebound in Relay Therapeutics Inc.July 2025 Opening Moves & Capital Protection Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can a trend reversal in Relay Therapeutics Inc. lead to recoveryMarket Risk Report & Capital Efficiency Focused Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Short interest data insights for Relay Therapeutics Inc.July 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Relay Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Gains Summary & Smart Investment Allocation Tips - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Does Relay Therapeutics Inc. qualify in momentum factor screening2025 Volatility Report & Weekly High Momentum Picks - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Relay Therapeutics Inc. stock poised for growth2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is Relay Therapeutics Inc. stock bottoming outWatch List & Free Verified High Yield Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Relay Therapeutics, Inc. $RLAY Shares Sold by Voya Investment Management LLC - Defense World

Oct 02, 2025
pulisher
Sep 30, 2025

Is Relay Therapeutics Inc a good long term investmentPrice Action Analysis & Affordable Market Trading - earlytimes.in

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Relay Therapeutics Inc stockPrice Action Analysis & Affordable Market Growth - earlytimes.in

Sep 28, 2025
pulisher
Sep 26, 2025

Relay Therapeutics (NASDAQ:RLAY) Shares Up 7%Time to Buy? - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Institutional scanner results for Relay Therapeutics Inc.July 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com

Sep 26, 2025
pulisher
Sep 22, 2025

Relay Therapeutics (NASDAQ:RLAY) Trading 7.9% HigherTime to Buy? - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Relative strength of Relay Therapeutics Inc. in sector analysisTrade Signal Summary & Safe Entry Zone Identification - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 - Yahoo Finance

Sep 21, 2025
pulisher
Sep 21, 2025

Analysts Set Relay Therapeutics, Inc. (NASDAQ:RLAY) Price Target at $16.50 - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Acadian Asset Management LLC Buys 653,081 Shares of Relay Therapeutics, Inc. $RLAY - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Goldman Sachs Group Inc. Sells 627,974 Shares of Relay Therapeutics, Inc. $RLAY - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Relay Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo

Sep 19, 2025
pulisher
Sep 19, 2025

Volatility Watch: Can Relay Therapeutics Inc expand its profit marginsMarket Movement Recap & Expert Verified Stock Movement Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

History Review: What are Relay Therapeutics Incs growth leversEarnings Miss & Low Risk Growth Stock Ideas - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Bull Bear: Whats the beta of Relay Therapeutics Inc stockWeekly Investment Summary & Long-Term Safe Return Strategies - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Growth Value: Should I hold or sell REGCO now2025 Market Trends & Fast Gain Swing Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Opening: Is Unifi Inc. subject to activist investor interestVolume Spike & Advanced Swing Trade Entry Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Spikes: Can Relay Therapeutics Inc expand into new markets2025 Trading Volume Trends & Stepwise Trade Execution Plans - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Growth Review: Will Relay Therapeutics Inc benefit from government policy2025 Short Interest & Weekly Top Performers Watchlists - خودرو بانک

Sep 18, 2025

Relay Therapeutics Inc Stock (RLAY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Relay Therapeutics Inc Stock (RLAY) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Rahmer Peter
See remarks
Jul 28 '25
Sale
3.74
1,359
5,083
393,722
Catinazzo Thomas
Chief Financial Officer
Jul 29 '25
Sale
3.68
18,380
67,638
335,295
Catinazzo Thomas
Chief Financial Officer
Jul 28 '25
Sale
3.74
1,701
6,362
353,675
Bergstrom Donald A
President, R&D
Jul 29 '25
Sale
3.68
26,701
98,260
552,720
Bergstrom Donald A
President, R&D
Jul 28 '25
Sale
3.74
4,069
15,218
579,421
Adams Brian
Chief Legal Officer
Jul 29 '25
Sale
3.68
18,276
67,256
371,472
Adams Brian
Chief Legal Officer
Jul 28 '25
Sale
3.74
1,637
6,122
389,748
Patel Sanjiv
President and CEO
Jul 09 '25
Sale
3.57
61,379
219,123
765,288
Rahmer Peter
See remarks
Apr 30 '25
Sale
3.00
10,739
32,217
390,081
Rahmer Peter
See remarks
Apr 28 '25
Sale
3.17
1,364
4,324
400,820
$85.13
price up icon 1.59%
$22.83
price up icon 7.21%
$32.80
price up icon 3.03%
$102.59
price up icon 0.56%
$165.04
price up icon 1.60%
biotechnology ONC
$330.86
price up icon 3.39%
Cap:     |  Volume (24h):